JPMorgan Chase is structuring auto callable contingent interest notes linked to Axon common stock, offering at least a 21.80% annual contingent rate through September 27, 2029. For investors, payments depend on Axon staying at or above a 50.00% barrier, while estimated value is below the $1,000 principal amount.

Key Highlights

  • JPMorgan Chase Financial Company LLC is the issuer, with JPMorgan Chase & Co providing the guarantee.
  • Selling commissions are capped at $3.50 for each $1,000 principal amount note.
  • The notes’ estimated value is approximately $969.90 per $1,000 principal amount.

JPMorgan Chase & Co is a Banks - Diversified company. JPMorgan Chase Financial Company LLC is structuring auto callable contingent interest notes tied to Axon Enterprise, Inc. (NASDAQ: AXON) common stock, with a minimum contingent rate of 21.80% per annum. The securities mature on September 27, 2029, and JPMorgan Chase & Co fully and unconditionally guarantees them.

Axon-Linked Notes Set Interest Threshold

The reference stock is Axon Enterprise, Inc. common stock, which has a Par Value of $0.00001 per share. Each $1,000 principal amount note may pay at least $18.1667 on an applicable Interest Payment Date when Axon’s closing price reaches the required level. The Interest Barrier equals 50.00% of the $225.305 Strike Value. The notes can be automatically called under the terms described in the pricing supplement, with the pricing date expected on or about September 24, 2026. The estimated value is approximately $969.90 per $1,000 principal amount and will be no lower than $930.00 per $1,000 when the terms are set.

Estimated Value Below Original Issue Price

The notes’ estimated value is below their original issue price because that price includes selling commissions, projected hedging profits or losses, hedging expenses and possible third-party data or platform fees. JPMorgan Chase says the estimated figure is not a forecast of future note values and may differ from other estimates. The value uses an internal funding rate that may differ from market-implied funding rates for comparable conventional fixed-income instruments. Changes in that internal rate may adversely affect the notes’ terms and secondary-market prices.